Clinical Trial Update: Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating nicorandil in patients with stable angina due to coronary heart disease has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Stable Angina

Drugs mentioned

• Nicorandil (nicorandil)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Stable Angina, Coronary Disease | Phase 4 | Status: COMPLETED | Results posted: 2016-04-14